Opal Oncology is a single asset company based on a programme that was licensed in from Hershey Cancer Research, USA to develop a novel treatment against Glioblastoma.
| Status | Active |
| Website | http://www.opalonc.com/ |
| Category | Biotech |
| Modality | Small Molecule |
| Headquarters | Cambridge, UK |
| Partner | Business Angels |
| Investment Portfolio | Pre-Fund Investment |
| Co-Investors | Hershey Cancer Research |